Cargando…

Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events

BACKGROUND: The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) have not been assessed. Therefore, we aimed to assess its validity, reliability, and responsiveness. PATIENTS AND METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shan-Shan, Chen, Lei, Liu, Ying, Lu, Hai-Jun, Huang, Bo-Jie, Lin, Ai-Hua, Sun, Ying, Ma, Jun, Xie, Fang-Yun, Mao, Yan-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314582/
https://www.ncbi.nlm.nih.gov/pubmed/34315423
http://dx.doi.org/10.1186/s12885-021-08610-0
_version_ 1783729580832456704
author Yang, Shan-Shan
Chen, Lei
Liu, Ying
Lu, Hai-Jun
Huang, Bo-Jie
Lin, Ai-Hua
Sun, Ying
Ma, Jun
Xie, Fang-Yun
Mao, Yan-Ping
author_facet Yang, Shan-Shan
Chen, Lei
Liu, Ying
Lu, Hai-Jun
Huang, Bo-Jie
Lin, Ai-Hua
Sun, Ying
Ma, Jun
Xie, Fang-Yun
Mao, Yan-Ping
author_sort Yang, Shan-Shan
collection PubMed
description BACKGROUND: The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) have not been assessed. Therefore, we aimed to assess its validity, reliability, and responsiveness. PATIENTS AND METHODS: A Chinese version of the PRO-CTCAE and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (QLQ-C30) were distributed to 1580 patients from four cancer hospitals in China. Validity assessments included construct validity, measured by Pearson’s correlations and confirmatory factor analysis (CFA), and known-groups validity, measured by t-tests. The assessment of reliability included internal consistency, measured by Cronbach’s ɑ, and test-retest reliability, measured by the intraclass correlation (ICC). Responsiveness was assessed by standardized response means (SRMs). RESULTS: Data from 1555 patients who completed the instruments were analyzed. The correlations were high between PRO-CTCAE items and parallel QLQ-C30 symptom scales (r > 0.60, p < 0.001), except for fatigue (severity: r = 0.49). Moreover, CFA showed the PRO-CTCAE structure was a good fit with the data (Root Mean Square Error of Approximation = 0.046). Known-groups validity was also confirmed. Cronbach’s ɑ of all item clusters were greater than 0.9 and the median test-retest reliability coefficients of the 38 items were 0.85 (range = 0.71–0.91). In addition, the SRMs of PRO-CTCAE items were greater than 0.8, indicating strong responsiveness. CONCLUSION: The simplified Chinese version of the PRO-CTCAE showed good reliability, validity, and responsiveness. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-08610-0.
format Online
Article
Text
id pubmed-8314582
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83145822021-07-28 Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events Yang, Shan-Shan Chen, Lei Liu, Ying Lu, Hai-Jun Huang, Bo-Jie Lin, Ai-Hua Sun, Ying Ma, Jun Xie, Fang-Yun Mao, Yan-Ping BMC Cancer Research BACKGROUND: The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) have not been assessed. Therefore, we aimed to assess its validity, reliability, and responsiveness. PATIENTS AND METHODS: A Chinese version of the PRO-CTCAE and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (QLQ-C30) were distributed to 1580 patients from four cancer hospitals in China. Validity assessments included construct validity, measured by Pearson’s correlations and confirmatory factor analysis (CFA), and known-groups validity, measured by t-tests. The assessment of reliability included internal consistency, measured by Cronbach’s ɑ, and test-retest reliability, measured by the intraclass correlation (ICC). Responsiveness was assessed by standardized response means (SRMs). RESULTS: Data from 1555 patients who completed the instruments were analyzed. The correlations were high between PRO-CTCAE items and parallel QLQ-C30 symptom scales (r > 0.60, p < 0.001), except for fatigue (severity: r = 0.49). Moreover, CFA showed the PRO-CTCAE structure was a good fit with the data (Root Mean Square Error of Approximation = 0.046). Known-groups validity was also confirmed. Cronbach’s ɑ of all item clusters were greater than 0.9 and the median test-retest reliability coefficients of the 38 items were 0.85 (range = 0.71–0.91). In addition, the SRMs of PRO-CTCAE items were greater than 0.8, indicating strong responsiveness. CONCLUSION: The simplified Chinese version of the PRO-CTCAE showed good reliability, validity, and responsiveness. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-08610-0. BioMed Central 2021-07-27 /pmc/articles/PMC8314582/ /pubmed/34315423 http://dx.doi.org/10.1186/s12885-021-08610-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yang, Shan-Shan
Chen, Lei
Liu, Ying
Lu, Hai-Jun
Huang, Bo-Jie
Lin, Ai-Hua
Sun, Ying
Ma, Jun
Xie, Fang-Yun
Mao, Yan-Ping
Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events
title Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events
title_full Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events
title_fullStr Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events
title_full_unstemmed Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events
title_short Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events
title_sort validity and reliability of the simplified chinese patient-reported outcomes version of the common terminology criteria for adverse events
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314582/
https://www.ncbi.nlm.nih.gov/pubmed/34315423
http://dx.doi.org/10.1186/s12885-021-08610-0
work_keys_str_mv AT yangshanshan validityandreliabilityofthesimplifiedchinesepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseevents
AT chenlei validityandreliabilityofthesimplifiedchinesepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseevents
AT liuying validityandreliabilityofthesimplifiedchinesepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseevents
AT luhaijun validityandreliabilityofthesimplifiedchinesepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseevents
AT huangbojie validityandreliabilityofthesimplifiedchinesepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseevents
AT linaihua validityandreliabilityofthesimplifiedchinesepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseevents
AT sunying validityandreliabilityofthesimplifiedchinesepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseevents
AT majun validityandreliabilityofthesimplifiedchinesepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseevents
AT xiefangyun validityandreliabilityofthesimplifiedchinesepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseevents
AT maoyanping validityandreliabilityofthesimplifiedchinesepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseevents